Swedish Orphan Biovitrum Competitors and Similar CompaniesClear all
Swedish Orphan Biovitrum's competitors and similar companies include Zentiva, TRB Chemedica, Livzon Pharmaceutical Group and UCB.
 Swedish Orphan Biovitrum Swedish Orphan Biovitrum (Sobi) is an integrated biotechnology company that researches, develops, manufactures, and sells treatments in the areas of hematology, immunology, and specialty care. |  TRB Chemedica TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices. |  Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ||
Founding Date | Founding Date 2010 | Founding Date 2003 | Founding Date 1980 | Founding Date 1985 | Founding Date 1928 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Genève, CH HQ Buenos Aires, AR Biedermannsdorf, AT Campinas, BR Archamps, FR Feldkirchen, DE Sai Ying Pun, HK see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | ||
Employees | Employees 1,814 | Employees 3,441 | Employees 900 | Employees 8,933 | Employees 9,000 |
Valuation ($) | Valuation ($) 11.1 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 4.2 b | Valuation ($) 34.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) kr22.1b (FY, 2023) | Revenue (est.) Kč2.3b (FY, 2021) | Revenue (est.) N/A | Revenue (est.) ¥12.2b (FY, 2023) | Revenue (est.) €5.6b (FY, 2024) |
Cost of goods | Cost of goods kr4.9b (FY, 2023) | Cost of goods Kč807.2m (FY, 2021) | Cost of goods N/A | Cost of goods ¥4.5b (FY, 2023) | Cost of goods €1.1b (FY, 2024) |
Gross profit | Gross profit kr17.2b (FY, 2023) | Gross profit Kč1.5b (FY, 2021) | Gross profit N/A | Gross profit ¥7.8b (FY, 2023) | Gross profit €6.2b (FY, 2024) |
Net income | Net income kr2.4b (FY, 2023) | Net income (Kč831.2m) (FY, 2021) | Net income N/A | Net income ¥1.9b (FY, 2023) | Net income €1.1b (FY, 2024) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries 35 (Apr, 2023) | Countries N/A | Countries N/A | Countries 35 (FY, 2019) |
Trademark Applications | Trademark Applications N/A | Trademark Applications 4 (Apr, 2023) | Trademark Applications 4 (Jun, 2020) | Trademark Applications 3 (Sep, 2023) | Trademark Applications N/A |
Trademarks | Trademarks N/A | Trademarks 252 (Apr, 2023) | Trademarks N/A | Trademarks 45 (Sep, 2023) | Trademarks N/A |
For sources of this data, please see the company profile
View Company Profiles
Zentiva
HQ
CZ
Employees
3,441
Zentiva is a company that develops and manufactures generic medicines.
View companyTRB Chemedica
HQ
Genève, CH
Employees
900
TRB Chemedica is a company specializing in the production of active pharmaceutical ingredients (APIs), pharmaceutical products, and medical devices.
View companyLivzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
8,933
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyUCB
HQ
Brussels, BE
Employees
9,000
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company